- Home
- RCEL vs CPZ Comparison
RCEL vs CPZ Comparison
Compare RCEL & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- CPZ
- Stock Information
- Founded
- RCEL 2020
- CPZ 2019
- Country
- RCEL United States
- CPZ United States
- Employees
- RCEL N/A
- CPZ N/A
- Industry
- RCEL Medical/Dental Instruments
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- RCEL Health Care
- CPZ Finance
- Exchange
- RCEL Nasdaq
- CPZ Nasdaq
- Market Cap
- RCEL 342.7M
- CPZ 305.7M
- IPO Year
- RCEL N/A
- CPZ N/A
- Fundamental
- Price
- RCEL $11.77
- CPZ $15.28
- Analyst Decision
- RCEL Hold
- CPZ
- Analyst Count
- RCEL 3
- CPZ 0
- Target Price
- RCEL $16.50
- CPZ N/A
- AVG Volume (30 Days)
- RCEL 96.7K
- CPZ 63.0K
- Earning Date
- RCEL 02-20-2025
- CPZ 01-01-0001
- Dividend Yield
- RCEL N/A
- CPZ 11.07%
- EPS Growth
- RCEL N/A
- CPZ N/A
- EPS
- RCEL N/A
- CPZ N/A
- Revenue
- RCEL $60,040,000.00
- CPZ N/A
- Revenue This Year
- RCEL $40.34
- CPZ N/A
- Revenue Next Year
- RCEL $52.79
- CPZ N/A
- P/E Ratio
- RCEL N/A
- CPZ N/A
- Revenue Growth
- RCEL 32.24
- CPZ N/A
- 52 Week Low
- RCEL $7.51
- CPZ $13.17
- 52 Week High
- RCEL $18.93
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- RCEL 43.48
- CPZ 45.10
- Support Level
- RCEL $11.30
- CPZ $14.86
- Resistance Level
- RCEL $12.75
- CPZ $15.67
- Average True Range (ATR)
- RCEL 0.74
- CPZ 0.23
- MACD
- RCEL -0.24
- CPZ -0.04
- Stochastic Oscillator
- RCEL 18.01
- CPZ 40.63
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.